Issue Date | Title | Involved Person(s) |
17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
2021 | Prophylactic effects or withdrawal reactions? : an analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA | Hengartner, Michael Pascal; Plöderl, Martin |
2021 | Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses | Juul, Sophie; Siddiqui, Faiza; Barbateskovic, Marija; Jørgensen, Caroline Kamp; Hengartner, Michael Pascal, et al |
2021 | Suicidality and other severe psychiatric events with duloxetine : re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia | Hengartner, Michael Pascal; Plöderl, Martin |
2021 | Swiss GPs’ preferences for antidepressant treatment in mild depression : vignette-based quantitative analysis | Hengartner, Michael P.; Neuner-Jehle, Stefan; Senn, Oliver |
2021 | Overlap between general factors of psychopathology and personality : they share associations with daily life functioning and communication style | van der Linden, Dimitri; Dunkel, Curtis S.; Prinzie, Peter; Yamanaka-Altenstein, Misa; von Wyl, Agnes, et al |
2021 | Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder : a protocol for a systematic review with meta-analysis and Trial Sequential Analysis | Jørgensen, Caroline Kamp; Juul, Sophie; Siddiqui, Faiza; Barbateskovic, Marija; Munkholm, Klaus, et al |